| scholarly article | Q13442814 |
| P50 | author | Francesco Tommasino | Q57204198 |
| Marco Durante | Q37834971 | ||
| P2093 | author name string | Shigeru Yamada | |
| P2860 | cites work | Recent progress in pancreatic cancer | Q24626346 |
| Proton radiobiology | Q27025061 | ||
| Cancer statistics, 2015 | Q27860576 | ||
| Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer | Q28248396 | ||
| Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer | Q29547558 | ||
| Phase II study of bevacizumab with concurrent capecitabine and radiation followed by maintenance gemcitabine and bevacizumab for locally advanced pancreatic cancer: Radiation Therapy Oncology Group RTOG 0411 | Q30434934 | ||
| Radiation dose responses for chemoradiation therapy of pancreatic cancer: an analysis of compiled clinical data using biophysical models | Q30775777 | ||
| Concurrent chemoradiotherapy treatment of locally advanced pancreatic cancer: gemcitabine versus 5-fluorouracil, a randomized controlled study | Q33349410 | ||
| Phase I-II trial of twice-weekly gemcitabine and concomitant irradiation in patients undergoing pancreaticoduodenectomy with extended lymphadenectomy for locally advanced pancreatic cancer | Q33362723 | ||
| Gemcitabine/cisplatin versus 5-fluorouracil/mitomycin C chemoradiotherapy in locally advanced pancreatic cancer: a retrospective analysis of 93 patients | Q33396393 | ||
| Analysis of the clinical benefit of 5-fluorouracil and radiation treatment in locally advanced pancreatic cancer | Q33733181 | ||
| New challenges in high-energy particle radiobiology | Q33782346 | ||
| Definitive concurrent chemoradiotherapy in locally advanced pancreatic cancer | Q33923018 | ||
| The radiosensitising effect of gemcitabine and its main metabolite dFdU under low oxygen conditions is in vitro not dependent on functional HIF-1 protein | Q34123758 | ||
| Promise and pitfalls of heavy-particle therapy | Q34124263 | ||
| S-1 plus gemcitabine chemotherapy followed by concurrent radiotherapy and maintenance therapy with S-1 for unresectable pancreatic cancer | Q34326711 | ||
| Intensity modulated radiotherapy for locally advanced and metastatic pancreatic cancer: a mono-institutional retrospective analysis | Q34976612 | ||
| A phase 2 trial of gemcitabine, 5-fluorouracil, and radiation therapy in locally advanced nonmetastatic pancreatic adenocarcinoma : cancer and Leukemia Group B (CALGB) 80003. | Q35050606 | ||
| Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: correlation of Smad4(Dpc4) immunostaining with pattern of disease progression | Q35170212 | ||
| Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma | Q35202400 | ||
| Docetaxel- and 5-FU-concurrent radiotherapy in patients presenting unresectable locally advanced pancreatic cancer: a FNCLCC-ACCORD/0201 randomized phase II trial's pre-planned analysis and case report of a 5.5-year disease-free survival. | Q35319001 | ||
| Combination of carbon ion beam and gemcitabine causes irreparable DNA damage and death of radioresistant pancreatic cancer stem-like cells in vitro and in vivo | Q35742348 | ||
| Whole genomes redefine the mutational landscape of pancreatic cancer | Q35911034 | ||
| 21 years of biologically effective dose | Q36324701 | ||
| Treatment of locally advanced unresectable pancreatic cancer: a 10-year experience | Q36381222 | ||
| Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial | Q36476666 | ||
| Weekly full-dose gemcitabine and single-dose cisplatin with concurrent radiotherapy in patients with locally advanced pancreatic cancer. | Q36494203 | ||
| Phase II study of radiotherapy combined with gemcitabine for locally advanced pancreatic cancer | Q36626082 | ||
| Stereotactic body radiation therapy with concurrent full-dose gemcitabine for locally advanced pancreatic cancer: a pilot trial demonstrating safety | Q36715792 | ||
| The potential for mathematical modelling in the assessment of the radiation dose equivalent of cytotoxic chemotherapy given concomitantly with radiotherapy. | Q51964012 | ||
| Long-term results of full-dose gemcitabine with radiation therapy compared to 5-fluorouracil with radiation therapy for locally advanced pancreas cancer. | Q53222319 | ||
| Combined radiotherapy and chemotherapy (cisplatin and 5-fluorouracil) as palliative treatment for localized unresectable or adjuvant treatment for resected pancreatic adenocarcinoma: results of a feasibility study. | Q53527669 | ||
| Gemcitabine chemotherapy versus 5-fluorouracil-based concurrent chemoradiotherapy in locally advanced unresectable pancreatic cancer. | Q53585423 | ||
| Pancreatic Cancer | Q54135367 | ||
| Four-Dimensional Patient Dose Reconstruction for Scanned Ion Beam Therapy of Moving Liver Tumors | Q57780530 | ||
| Particle radiosurgery: A new frontier of physics in medicine | Q57780552 | ||
| Induction Chemotherapy With Gemcitabine, Oxaliplatin, and 5-Fluorouracil/Leucovorin Followed by Concomitant Chemoradiotherapy in Patients With Locally Advanced Pancreatic Cancer: A Taiwan Cooperative Oncology Group Phase II Study | Q58215184 | ||
| Induction Gemcitabine and Stereotactic Body Radiotherapy for Locally Advanced Nonmetastatic Pancreas Cancer | Q63197288 | ||
| Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study | Q70937645 | ||
| Results of a phase II trial of epirubicin and cisplatin (EP) before and after irradiation and 5-fluorouracil in locally advanced pancreatic cancer: an EORTC GITCCG study | Q71680920 | ||
| Pancreatic tumors show high levels of hypoxia | Q73173983 | ||
| Protracted 5-fluorouracil infusion with concurrent radiotherapy as a treatment for locally advanced pancreatic carcinoma | Q73265762 | ||
| Proceedings of the 25th National Congress of the Italian Association of Pancreatology Study (AISP). Cernobbio, Como (Italy). September 20-22, 2001 | Q77726040 | ||
| Full-dose gemcitabine and concurrent radiotherapy for unresectable pancreatic cancer | Q80017697 | ||
| Phase-II study on stereotactic radiotherapy of locally advanced pancreatic carcinoma | Q81912561 | ||
| Phase II study of radiation therapy combined with weekly low-dose gemcitabine for locally advanced, unresectable pancreatic cancer | Q82467952 | ||
| A phase II study of oral S-1 with concurrent radiotherapy followed by chemotherapy with S-1 alone for locally advanced pancreatic cancer | Q84290181 | ||
| Phase II study of oral S-1 and concurrent radiotherapy in patients with unresectable locally advanced pancreatic cancer | Q84530534 | ||
| Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial. | Q36751555 | ||
| Randomized phase III multi-institutional study of TNFerade biologic with fluorouracil and radiotherapy for locally advanced pancreatic cancer: final results | Q36764997 | ||
| SBRT in unresectable advanced pancreatic cancer: preliminary results of a mono-institutional experience. | Q37000899 | ||
| Radio-chemotherapy for bladder cancer: Contribution of chemotherapy on local control | Q37135495 | ||
| Combined radiochemotherapy in patients with locally advanced pancreatic cancer: a meta-analysis | Q37317498 | ||
| Chemoradiotherapy with twice-weekly administration of low-dose gemcitabine for locally advanced pancreatic cancer. | Q37347058 | ||
| Phase II Trial of Cetuximab and Conformal Radiotherapy Only in Locally Advanced Pancreatic Cancer with Concurrent Tissue Sampling Feasibility Study | Q37721562 | ||
| Single-fraction stereotactic body radiation therapy and sequential gemcitabine for the treatment of locally advanced pancreatic cancer | Q37872911 | ||
| Charged particle therapy--optimization, challenges and future directions | Q38108208 | ||
| Immunologically augmented cancer treatment using modern radiotherapy | Q38119797 | ||
| Can the two mechanisms of tumor cell killing by radiation be exploited for therapeutic gain? | Q38150778 | ||
| Stereotactic body radiation therapy in pancreatic cancer: the new frontier | Q38245676 | ||
| Carbon ion radiotherapy in Japan: an assessment of 20 years of clinical experience | Q38339108 | ||
| Comparison of the effects of photon versus carbon ion irradiation when combined with chemotherapy in vitro | Q39066862 | ||
| In vitro evaluation of photon and raster-scanned carbon ion radiotherapy in combination with gemcitabine in pancreatic cancer cell lines | Q39125807 | ||
| Motion mitigation in scanned ion beam therapy through 4D-optimization | Q39194202 | ||
| 5-fluorouracil-based chemoradiation in unresectable pancreatic carcinoma: Phase I-II dose-escalation study. | Q39378011 | ||
| Feasibility and efficacy of high dose conformal radiotherapy for patients with locally advanced pancreatic carcinoma | Q39423266 | ||
| The role of apoptotic cell death in the radiosensitising effect of gemcitabine | Q39813658 | ||
| Paclitaxel and concurrent radiation for locally advanced pancreatic cancer | Q40715334 | ||
| Quantifying the position and steepness of radiation dose-response curves | Q41506193 | ||
| European cancer mortality predictions for the year 2015: does lung cancer have the highest death rate in EU women? | Q41523908 | ||
| Unresectable locally advanced pancreatic cancer: a multimodal treatment using neoadjuvant chemoradiotherapy (gemcitabine plus stereotactic radiosurgery) and subsequent surgical exploration. | Q43132182 | ||
| Phase I trial of gemcitabine combined with radiation for the treatment of locally advanced pancreatic adenocarcinoma. | Q43698908 | ||
| A phase I/II study of gemcitabine-concurrent proton radiotherapy for locally advanced pancreatic cancer without distant metastasis | Q43874046 | ||
| Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer | Q44125609 | ||
| Phase II study of gemcitabine combined with radiation therapy in patients with localized, unresectable pancreatic cancer | Q44199019 | ||
| Radiation plus docetaxel and cisplatin in locally advanced pancreatic carcinoma: a non-comparative randomized phase II trial | Q44262602 | ||
| A multicenter phase II trial of S-1 with concurrent radiation therapy for locally advanced pancreatic cancer | Q45132488 | ||
| A prospective randomized study of gemcitabine with doxifluridine versus paclitaxel with doxifluridine in concurrent chemoradiotherapy for locally advanced pancreatic cancer | Q45181915 | ||
| Mapping of RBE-weighted doses between HIMAC- and LEM-Based treatment planning systems for carbon ion therapy. | Q45343566 | ||
| Assessment of the radiation-equivalent of chemotherapy contributions in 1-phase radio-chemotherapy treatment of muscle-invasive bladder cancer | Q45864172 | ||
| Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of | Q46604466 | ||
| A randomized phase III study of radiotherapy alone or with 5-fluorouracil and mitomycin-C in patients with locally advanced adenocarcinoma of the pancreas: Eastern Cooperative Oncology Group study E8282. | Q46608868 | ||
| Gemcitabine chemotherapy and single-fraction stereotactic body radiotherapy for locally advanced pancreatic cancer | Q46659113 | ||
| Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: a multicenter phase II trial | Q46748088 | ||
| Gemcitabine, cisplatin, and radiotherapy for patients with locally advanced pancreatic adenocarcinoma: results of the North Central Cancer Treatment Group Phase II Study N9942. | Q48464441 | ||
| Examination of GyE system for HIMAC carbon therapy. | Q51287295 | ||
| Four-dimensional treatment planning in layer-stacking boost irradiation for carbon-ion pancreatic therapy. | Q51729039 | ||
| A phase II study of gemcitabine in combination with radiation therapy in patients with localized, unresectable, pancreatic cancer: a Hoosier Oncology Group study. | Q51750143 | ||
| P921 | main subject | heavy ion radiotherapy | Q493976 |
| pancreatic cancer | Q212961 | ||
| P304 | page(s) | 145 | |
| P577 | publication date | 2015-07-06 | |
| P1433 | published in | Frontiers in Oncology | Q26839986 |
| P1476 | title | Modeling Combined Chemotherapy and Particle Therapy for Locally Advanced Pancreatic Cancer | |
| P478 | volume | 5 |
| Q61798087 | 4DMRI-based investigation on the interplay effect for pencil beam scanning proton therapy of pancreatic cancer patients |
| Q36430664 | Charged particles for liver cancer. |
| Q38746213 | Charged-particle therapy in cancer: clinical uses and future perspectives |
| Q94544900 | Evaluating dosimetric constraints for carbon ion radiotherapy in the treatment of locally advanced pancreatic cancer |
| Q41863407 | Improved Survival in Patients with Resected Pancreatic Carcinoma Using Postoperative Intensity-Modulated Radiotherapy and Regional Intra-Arterial Infusion Chemotherapy. |
Search more.